Gregory L. Weaver, Chief Financial Officer at Altimmune, Inc. (ALT), bought 10,000 shares at $5.20 ($52K) on 2025-03-13, disclosed to the SEC on 2025-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ATOS | SELL | 2023-11-17 | $33K | — | Filing → |
| ATOS | BUY | 2023-06-20 | $49K | — | Filing → |
| ATOS | SELL | 2021-07-07 | $1.2M | — | Filing → |